Rapid Point-of-Care Assays

Jan Gorm Lisby, Uffe Vest Schneider

Abstract

Nucleic acid amplification-based technologies have matured, and gold standard clinical virology diagnostics is now undergoing a paradigm shift from being confined within the central laboratory to moving close to the patient. This new rapid Point-of-Care diagnostic approach may lead to positive impact on patient management and patient outcomes, such as better use of contact isolation facilities, prudent use of antimicrobials and shorter length of stay in the hospital. Point-of-Care diagnostics may, however, present potential problems, such as reduced diagnostic quality, loss of data and compromised surveillance, if the implementation process is uncontrolled.
Original languageEnglish
Title of host publicationReference Module in Life Sciences
Number of pages7
Volume5
PublisherElsevier Ltd
Publication date2021
Edition4
Pages45-51
Publication statusPublished - 2021

Fingerprint

Dive into the research topics of 'Rapid Point-of-Care Assays'. Together they form a unique fingerprint.

Cite this